MKP-5 inhibition blunts fibrotic responses in-vitro and in-vivo through negative regulation of TGFB1-induced smad3-signalling

A. Tzouvelekis (Athens, Greece), N. Xylourgidis (New Haven, United States of America), K. Min (New Haven, United States of America), T. Karampitsakos (Athens, Greece), I. Ninou (Athens, Greece), I. Barbayianni (Athens, Greece), A. Bennett (New Haven, United States of America), V. Aidinis (AthensHaven, Greece), N. Kaminski (AthensHaven, Greece)

Source: International Congress 2018 – New insights in the signalling pathways that underlie IPF pathophysiology
Session: New insights in the signalling pathways that underlie IPF pathophysiology
Session type: Oral Presentation
Number: 5350
Disease area: Interstitial lung diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Tzouvelekis (Athens, Greece), N. Xylourgidis (New Haven, United States of America), K. Min (New Haven, United States of America), T. Karampitsakos (Athens, Greece), I. Ninou (Athens, Greece), I. Barbayianni (Athens, Greece), A. Bennett (New Haven, United States of America), V. Aidinis (AthensHaven, Greece), N. Kaminski (AthensHaven, Greece). MKP-5 inhibition blunts fibrotic responses in-vitro and in-vivo through negative regulation of TGFB1-induced smad3-signalling. 5350

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
PP216 – Glucocorticoids exacerbate TGFß1 mediated fibrotic signalling in lung fibroblasts by inhibition of metalloproteinase expression and activity
Source: ERS Lung Science Conference 2021
Year: 2021

Hypoxia-dependent Fhl-1 regulation leads to proproliferative effects in PASMC
Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension
Year: 2008


Differential role of EPAC and PKA in the transduction of cAMP-mediated inhibition of human lung fibroblast proliferation and collagen synthesis
Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation
Year: 2009


Glucocorticoids promote TGF-β signalling in lung fibroblasts by upregulating ligand and receptor expression, and uncoupling negative-feedback inhibition
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases
Year: 2010

Inhibition of osteopontin modulates tumor-stimulated immune response and suppresses mesothelioma progression
Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions
Year: 2012



iNOS inhibition modulates lung tissue inflammation via oxidative stress pathway activation
Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD
Year: 2008


Selective inhibition of COX-2 by celecoxib exerts negative effects on endothelial progenitor cell proliferation and stimulates apoptosis in vitro
Source: Eur Respir J 2005; 26: Suppl. 49, 368s
Year: 2005

TGFβ induced myofibroblast differentiation is independent of p38 activation, but requires TGFβR1 kinase activity and correlates with TGFβ-mediated SMAD signaling and TGFβ-responsive gene expression patterns in human lung fibroblasts
Source: Eur Respir J 2004; 24: Suppl. 48, 718s
Year: 2004

Tankyrase(TNKS) inhibiting autophagy promotes the TGF-ß induced EMT process in vitro and Bleomycin(BLM) induced pulmonary fibrosis in rats
Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2019

The inhibitory mechanism of transferring iNOS gene to PASMCs on hypoxia induced proliferation
Source: Eur Respir J 2002; 20: Suppl. 38, 88s
Year: 2002

Follistatin-like 1 promotes intermittent hypoxia-induced lung fibroblast activation in vitro and in vivo
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019

Erythromycin restores HDAC2 levels diminished under oxidative and inflammatory stress in vitro and in vivo
Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD
Year: 2008

DJ-1 and its anti-oxidative stress response regulates the expression of sirtuin-1 in COPD epithelial cells
Source: International Congress 2017 – Translational studies of lung disease
Year: 2017

AntagomiR directed against miR-20a restores BMP signaling in hypoxia-induced pulmonary hypertension in vivo
Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease
Year: 2011

Targeting the Hippo signaling pathway to enhance ex vivo lung epithelial tissue regeneration and maturation
Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Year: 2019

c-Met expression induction in immune cells modulates pulmonary fibrosis progression
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020

PPAR-gamma modulates allergic inflammation through upregulation of PTEN
Source: Eur Respir J 2005; 26: Suppl. 49, 25s
Year: 2005

Evidence for potential autocrine regulation of human airway smooth muscle cell functions by neurokinins: modulation of gene expression by glucocorticoids
Source: Eur Respir J 2003; 22: Suppl. 45, 11s
Year: 2003

RB2/p130 gene-enhanced expression downregulates vascular endothelial growth factor expression and inhibits angiogenesis in vivo
Source: Eur Respir J 2002; 20: Suppl. 38, 3s
Year: 2002

A differential role for ceramide kinase in antigen/FcεRI mediated mast cell activation and function
Source: Eur Respir J 2006; 28: Suppl. 50, 231s
Year: 2006